Dengue vaccine was approved in three countries

Mosquitoes are the main cause dengue fever transmission among human beings each year, 400 million people are infected with the disease that finally, 22 thousand people, will be its victim. Recently, scientists and doctors fail to produce a vaccine that will prevent infection with dengue fever.

During the past month, Brazil, the Philippines and Mexico due to the weather conditions were very susceptible to the presence of disease-causing mosquitoes, dengue fever approved the first vaccine to be widely available to the public for public use. Since September, 100 cases of dengue infection in Hawaii reported that 29 of them related to persons under 18 years.

However, dengue vaccines are still not ideal enough, and certainly not stand against the disease. According to published reports, laboratory, this vaccine of 60% reduction in the risk of disease and for children under 9 years are also at risk. However, the vaccine against the most serious form of the disease, ie 95.5% of dengue hemorrhagic fever successful.

Every year, about 500 thousand people are infected with dengue hemorrhagic fever that killed much of the form as well. By taking advantage of this vaccine can be hoped that the number of cases and deaths each year could be reduced.

It is not clear that hospitals and health care facilities when and at what price will the vaccine to the public. Sanofi pharmaceutical company responsible for the drug's production and is now in talks with three countries mentioned.

World Health Organization plans in April this year dengue vaccine accurate evaluation of your case and then provide recommendations on how to use it.

Source: Scientific American